Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)
pharmaphorum
NOVEMBER 10, 2022
We can talk all the time, Montserrat said, but now is the time for action: early diagnosis, access to the best treatments, innovation, in addition to protection of intellectual property (IP), and after that biosimilars and generics. With 90% of adolescents that should be vaccinated by 2030, Luppi deems it an opportunity.
97 
Let's personalize your content